{"url_path":"/sec/pbm/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 THE OFFER AND LISTING","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","accession_number":"0001213900-26-070607","cik":"0001985062","ticker":"PBM","issuer_name":"PSYENCE BIOMEDICAL LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1985062/0001213900-26-070607-index.html","primary_entity_key":"0001985062","primary_entity_name":"PSYENCE BIOMEDICAL LTD."},"word_count":87,"has_tables":true,"body_markdown":"** **\n\nITEM 9. THE OFFER AND LISTING\n\n \n\nA. Offer and Listing Details\n\n \n\nNasdaq Listing of Common Shares and Warrants\n\n \n\nThe Common Shares and the\nWarrants are listed on Nasdaq under the symbols “PBM” and “PBMWW,” respectively. As of June 17, 2026, the closing\nprice of our Common Shares was $3.09 and our Warrants was $0.0307.\n\n** **\n\nB. Plan of Distribution\n\n \n\nNot applicable.\n\n \n\nC. Markets\n\n \n\nRefer to “Offer and Listing Details”\nin Item 9.A.\n\n** **\n\nD. Selling Shareholders\n\n \n\nNot applicable.\n\n** **\n\nE. Dilution\n\n \n\nNot applicable.\n\n** **\n\nF. Expenses of the Issue\n\n** **\n\nNot applicable."}